
uniQure has announced that it has entered a definitive agreement to sell a portion of the royalty rights due to …

Bristol-Myers Squibb (BMS) has signed a multi-million dollar agreement with Amsterdam-based gene therapy firm uniQure to boost research into new …

New contracts for Sanofi and Gallus, Fresenius Kabi sacks Indian managers, facility news from UniQure and Nextpharma plus BiG’s acquisition …

Dutch human gene therapy firm uniQure has appointed Hans Christian Rohde as chief commercial officer. Rohde joins uniQure from Basilea …

Glybera is now on the cusp of becoming the first gene therapy treatment to be approved in the West. The …

